Seth Iskowitz
Boston Children's Hospital
Internal medicineIngestionIntensive care unitPediatric gastroenterologyComorbidityEmpiric therapyForeign BodiesForeign bodyIntervention (counseling)Pediatric patientEsophageal sphincterHepatologyIncidence (epidemiology)AntibioticsBacteriaGeneral surgeryCephalosporinMedicineUrinary system
Publications 2
#1Yasemin Cagil (Lucile Packard Children's Hospital)
#2Jenna Diaz (WashU: Washington University in St. Louis)
Last. Alisa J. Muñiz Crim (Boston Children's Hospital)H-Index: 1
view all 4 authors...
#1Areej Bukhari (Boston Children's Hospital)H-Index: 1
#2Diana S Villacis Nunez (Boston Children's Hospital)
Last. Marcelo Laufer (Boston Children's Hospital)
view all 13 authors...
Background Urinary tract infections (UTIs) are a common cause for hospitalization in children. Inadequate treatment can lead to long-term renal damage. AAP guidelines recommend third-generation cephalosporins as empiric therapy. However, the incidence of community-acquired multiresistant, extended-spectrum β-lactamase (ESBL)-producing pathogens is rising. More research is needed to evaluate risk factors and management of ESBL UTI in children.